CD58 was aberrantly expressed between SLE patients and controls (P < 0.0001), but it not obvious in RA (P = 0.55), IBD (P = 0.11), and JIA (P = 0.09) (Figure 4). Here, CD58 is linked to inflammatory bowel disease.